Multiple Sclerosis Flashcards

1
Q

Most important factor in increasing survival for people with MS

A

normal physical and physiological stress does not activate the disease process

BED REST KILLS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Stages of MS Care

A

Phase I: disease of ambulation
Phase II: disease of several systems

*Phase III: (occurring now) complex disease whose management is patient-centered in which the total disability is more than the sum of all affected systems- seen as malfunction in the multitasking of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Definition of MS

A

Immune mediated inflammatory disease of the CNS
- characterized by exacerbations/ relapses (inflammatory attacks)

  • There is myelin damage and scarring and IRREVERSIBLE axonal damage in variable degrees
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T/F: Steroids help to gain back function.

A

FALSE.

Steroids will only decrease inflammatory response
Axons are destroyed (irreversible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Triggers of MS

A
  • abnormal immune response to virus
  • environmental trigger

in genetically susceptible individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathophysiology of MS

A

Activated peripheral t-cells break the blood-brain barrier
- they release chemicals that rally other immune system forces

  • Inflammatory response against myeline, axons, and oligodendocytes
  • Neurologic signs result from conduction blocks and axonal transection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Can myelin repair itself?

A

YES.

Once axons are damaged, they cannot be repaired.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Best time for treatment?

A

During an exacerbation to prevent damage to axon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Is MS hereditary?

A

No. But likely at risk in those with an affected relative compared to those with no family history.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Age of diagnosis?

A

Typically 20-50

90% of cases diagnosed between 16-60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T/F: MS is more common in women than men

A

TRUE

2-3:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Spinal MS

A
  • 55-75% of pts. have spinal cord lesions at some point

- 20% of patients with spinal lesions DO NOT intracranial plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Neuromyelitis optica (NMO)

A

Devic disease; sequential episodes of optic nerve involvement and a longitudinally extensive myelopathy

**MS treatments DO NOT WORK for this disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MS Classification (5)

A
  1. Relapse remitting MS
  2. Secondary progressive MS
  3. Primary progressive MS
  4. Progressive relapsing MS
  5. Malignant MS
  • Response to medications are different for each type
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the most common type of MS

A

Relapse remitting MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

RRMS

A

Acute attacks with full recovery or partial residual deficit

The disease does not progress between attacks

85% of people initially diagnosed with this form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When should you start exercising and medication?

A

Day of diagnosis

  • ultimately the patient’s choice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SPMS

A

Starts with RRMS followed by progression at a variable rate that may include occasional relapses and plateaus

More than 50% of the people with RRMS will transform to this type of MS in 10 years

90% within 25 years

19
Q

PPMS

A

Progression of disability from the onset with or without plateaus or remissions or minor improvements
- only 10% with this form

Male patients with this form have the worst prognosis

  • poor response to treatment
  • rapid accumulating disability
20
Q

PRMS

A

Progression from onset but with clear acute relapses

Only 5% diagnosed with this form

21
Q

Malignant MS

A

Very rare

Death usually occurs within 1 year of diagnosis

22
Q

Relapse

A

Symptoms lasting for more than one or two days
- TREAT EARLY TO PREVENT AXONAL DAMAGE

Inflammation is continuous– not usually picked up by MRI

  • leads to irreversible axonal damage
  • neurological impairments and long term disability
23
Q

Medications

A

slow down the disease process

24
Q

Diagnosis

A

Very difficult:

  • no symptom pattern
  • no single test

Based on:

  • clinical presentation
  • MRI– shows plaques
  • confirmed with lab tests
  • treated after first attack
25
What will an MRI show in people with MS?
- Lesions deep in the brain | - involvement of white matter
26
Lesions
Grouped into 4 patterns - each pattern may represent a separate disease - may show the same mechanism of demyelination
27
Classification System
Expanded Disability Status Scale (EDSS) - Kurtzke Scale - Quantifies disability in eight functional systems Scores: 1. 0- 4.5: fully ambulatory 5. 0- 9.5: impairment to ambulation
28
Symptoms
- Fatigue - Pain - Bowel/ bladder dysfunction - Visual disturbances - cognitive impairment - emotional changes
29
More symtpoms
- Tremor - Spasticity - Weakness - Imbalance - Incoordination - Sensory changes - Dysarthria - Dysphagia - Sexual dysfunction
30
Prognosis
1/3 will have a very mild course (no AD) 1/3 will have a moderate course 1/3 will become disabled
31
Prognostic indicators of a more favorable course:
- Female - Onset before 35 - Monoregional vs. polyregional lesions - Sensory vs. motor symptoms - complete recovery after exacerbation
32
Prognostic indicators of a less favorable course:
- Male - Onset after 35 - cerebellar symptoms - poor recovery following a relapse - Frequent attacks - African Americans
33
T/F: Rehab is an ongoing process
TRUE: In the health care system forever | - Frequent reassessments are required with the programs updated
34
Two aspects of medication
1. Immunomodulatory therapy | 2. Symptom modifying
35
Disease modifying Drugs
- Reduce the frequency of attacks - Reduce the scarring on MRI - Slows disease process THEY DO NOT: - cure disease - make people feel better - alleviate symptoms
36
Treatment strategies
- Steroids-- for relapses - symptom management - disease modification - psychosocial support - rehab : MAINTAIN/ IMPROVE FUNCTION
37
T/F: Treatment is effective during later, neurodegenerative phase
FALSE. Treatment is most effective during early, inflammatory phase. Damage has already occurred once diagnosis is made
38
Exercise
Decreases the deconditioning process that occurs on top of the neurological impairments Improves FUNCTION
39
PT Implications
Pts. have less muscle endurance and show increase in muscle fatigue Have 30% less aerobic capacity Relapses may account for memory loss and mood dysfunction.
40
What is the most common symptom?
FATIGUE - most troubling - lack of physical or mental energy perceived by the individual or caregiver
41
Types of Fatigue
Primary-- related to disease process Secondary-- caused by pathological consequences of the disease
42
Peripheral fatigue
happens at the muscle level - disuse - fiber type conversion - reduced oxidative capacity - impaired excitation - exaggerated metabolic response to exercise - impairment of calcium kinetics
43
What improves fatigue?
Rest after exercise (within 20-30 mintues) Medication: central fatigue Exercise: peripheral fatigue Aerobic exercise-- improve oxidative capacity